ITGAX and HIV-1 infection: While therapeutic treatment with rapamycin, clinically utilized as an immunosuppressant for transplantation patients, significantly reduced HIV-1 infection in tissue-derived CD11c+ DC subsets, therapeutic treatment with everolimus and carbamazepine did not (Fig. 3D).